Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05627960 |
|---|---|
| Brief Title: | First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies |
| First Submitted : | March 16, 2022 |
| First Submitted that Met QC Criteria : | November 16, 2022 |
| First Posted : | November 28, 2022 |
| Last Update Submitted that Met QC Criteria : | November 16, 2022 |
| Last Update Posted : | November 28, 2022 |